Skip to content
Riskpilot
← Back to search
Sign in
Get full access
Pharmetheus AB
AB
Active
Org 5568956352
Kungsängstull 4, 753 19
Uppsala
Engineering activities and related technical consultancy
·
NACE 7112
Est. 2012 · 14 years old
82 employees
Monitor
Share
Sweden
/
Companies
/
Engineering activities and related technical consultancy
/
Pharmetheus AB
Overview
Financials
People & ownership
Related companies
Loading company…
People & ownership
Management
Actively employed in the business
Name
Role
Member since
Current (3)
EL
Elodie Laetitia Plan
Chief Executive Officer
Chief Executive Officer
2024
PA
Peter Andrew Milligan
Chief Executive Officer
Chief Executive Officer
2020
JE
Johan Erik Niclas Bergenmo
Chief Auditor
Chief Auditor
2022
Former (2)
JK
Johanna Katarina Boive
Audit
Audit
2020 – 2022
EM
Eva Maria Andersson Dverstorp
Auditor Substitute
Auditor Substitute
2020 – 2022
Board of directors
Non-executive oversight
Name
Role
Member since
Current (5)
BM
Birgitta Marie Sandström
Board of Directors
Board of Directors
2024
BS
Bo Sverre Bengtsson
Board of Directors
Board of Directors
2024
BK
Birgit Köster Hoffmann
Board of Directors
Board of Directors
2022
MO
Mats Olof Karlsson
Board of Directors
Board of Directors
2020
MA
Magnus Axel Sigvard Forsbrand
Chairman
Chairman
2023
Former (6)
PT
Per Tomas Salomonsson
Board of Directors
Board of Directors
2022 – 2025
JP
Jan Per Martin Bergstrand
Board of Directors
Board of Directors
2020 – 2022
KJ
Karl Joakim Nyberg
Board of Directors
Board of Directors
2023 – 2024
SH
Sofia Helena Friberg Hietala
Board of Directors
Board of Directors
2020 – 2023
AI
Agneta Ingegerd Franksson
Board of Directors
Board of Directors
2022 – 2023
FV
Fredrik Veimar Alpsten
Board of Directors
Board of Directors
2020 – 2022
Shareholders
As of last annual report
Shareholder
Type
Ownership
Votes
Since
New Pharmetheus Holding AB
Company
100%
100%
2024
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive.
Learn more
.
More on Pharmetheus AB
Overview →
Headline figures, risk assessment and company summary
Financials & key figures →
Revenue, EBITDA, balance sheet and 5-year trend
Related companies →
Corporate hierarchy, parent and subsidiary network